Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-26-117881·Daewoong Co., Ltd
Schedule 13D ownership disclosure
AEON BIOPHARMA INC
Class A Common Stock, $0.0001 par value per share · CUSIP: 00791X209
Event date: 2026-10-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Daewoong Co., Ltd.Reported CIK 0001985493
Shares: 23,242,546.00 · Class: 30.6%
- Daewoong Pharmaceutical Co., Ltd.
Shares: 23,184,523.00 · Class: 30.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-117881
- Form type
- SCHEDULE 13D/A
- Filer
- Daewoong Co., Ltd
- CIK
- CIK 1985493
- Filed
- Nov 10, 2026
- Reporting period
- Oct 30, 2026
- Description
- Schedule 13D beneficial ownership